Interferon and ribavirin treatment in a rhesus macaque model of novel Middle East respiratory syndrome coronavirus (MERS-CoV) infection (hCoV-EMC)
Ontology highlight
ABSTRACT: Microarray analysis of lungs (right lower lobe) on day 3 post-infection with MERS-CoV with and without treatment beginning 8 h post-infection with intravenous type I interferon (IFN) and ribavirin (RBV). Dosages are as follows: IFN a2b 5 million IU/kg s.c. q8, RBV loading dose 50mg/kg i.v.; RBV maintenance dose 10mg/kg i.m. q8 6 rhesus macaques were infected with 7x10e6 TCID50 total (4x10e6 intratracheal, 1x10e6 oral, 1x10e6 intranasal, 1x10e6 intraocular)
ORGANISM(S): Macaca mulatta
SUBMITTER: Michael Katze
PROVIDER: E-GEOD-47957 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA